Previous month:
May 2009
Next month:
July 2009

Botox for Hair Loss

From migranes to wrinkles to sweaty palms, muscle-paralyzing BOTOX has been a 'wonder-drug' of sorts. However, I'm skeptical about Dr. Ourian's hair raising 'discovery' now hitting the UK press(The Sun) and making the rounds again on FOX news:
http://www.foxnews.com/story/0,2933,528411,00.html


Back in February 2009, when the story originally broke in the U.S., I mentioned to some patients that the hair regrowth Dr. O. observed in his mother might have something more to do with her recently stopping chemo (regrowth typically takes 12-14 months after chemo) than with the Botox injections for her headaches.

Botox for hair loss would be quite a long-shot (not to mention, expensive!) especially considering there's no published, peer-reviewed articles and not a single photo of a result, anywhere!

For now, hair loss patients are best to stick with the FDA-approved treatments/procedures recommended by board-certified hair docs.

On a separate, but releated topic, Dr. Jerry Shapiro, a colleage and friend in Canada/BC registered a clinical trial with the US-NIH on Botox for Alopecia Areata back in 2006,  http://clinicaltrials.gov/ct2/show/NCT00408798, but no recruitment has started.

 


NeoGraft Live Surgery Workshop | Advanced Hair Transplant Technique

neograft workshop 6-26-09

A Live Surgery Workshop will be held at Bauman Medical Group in Boca Raton Florida on June 26th, 2009 highlighting an overview and introduction to the use of the NeoGraft device in Follicular-Unit Extraction hair transplantation procedures. 

Topics will include:

  • Hair Transplantation via Follicular-Unit Extraction (FUE)
  • Follicular Unit Extraction using NeoGraft™
  • Patient Selection Pearls
  • Non-Invasive Medical Treatments for Androgenetic Alopecia
  • Linear Harvesting vs. FUE approach
  • NeoGraft™ vs. alternative methods of FUE harvesting
  • Using NeoGraft™ for ‘no-touch’ graft implantation
  • Post-op care and healing of FUE
  • Interactive Q&A and "live" procedure observation

Please Note:  This Live Surgery Workshop is for physicians and surgical technicians only who possess an intermediate to advanced skill level in hair transplantation.  Registration space is limited.  For more information on this and future workshops, please call 561-394-0024. 


The Science Behind LLLT--what are the mechanisms of action of laser therapy?

American Society for Photobiology

 

Symposium: 7-8 AUG / U of Rochester / NY USA

Over the past 40 years there have been many seemingly extraordinary claims of successful treatments of a wide range of diseases, dysfunctions and injuries through the use of “low-level” laser (or light) therapy (LLLT). Many different terms have been used - from LLLT to “biostimulation,” “photobiomodulation,” and other terms. Claims ranging from wound healing, analgesia, reduction of inflammation and nerve regeneration have been seriously questioned by the scientific community and met with great skepticism by much of the medical community. Since irradiances are below levels that produce any significant increase in tissue temperature, it is generally agreed that if these photobiological treatments are real, then they are photochemical rather than photothermal in nature. Although there are now FDA-cleared LLLT treatments and growing acceptance from some quarters, the scientific acceptance has been routinely set back by poorly designed, less-than-rigorous experimental and clinical studies.

Clearly presented photobiological dosimetry and recognition of fundamental methodology in the field of photobiology have frequently been lacking. The aim of this ASP symposium is to explore the scientific evidence for the photobiological mechanisms behind LLLT—from molecular biology to cell and tissue level, and to review those clinical results that appear to be well founded. Ample time has been planned for discussion after each review of the key scientific

questions from action spectra to temporal and spatial factors that appear to influence outcome.

Register at: www.pol-us.net/ASP_Home/asp_meet.html



June Newsletter from Bauman Medical Group: FUE - NeoGraft - Zerona

The June 2009 newsletter from Bauman Medical Group contained information on the less invasive hair transplant process called "FUE" or Follicular Unit Extraction using the NeoGraft device.  It also highlights the new non-invasive genetic test which can now predict your response to finasteride (Propecia).

View the June Newsletter: http://archive.constantcontact.com/fs050/1010982112114/archive/1102486345394.html

Don't miss another... sign up here:

For Email Marketing you can trust